We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-12.35%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$14.3B
AUM Growth
-$444M
Cap. Flow
+$1.68B
Cap. Flow %
11.73%
Top 10 Hldgs %
21.62%
Holding
1,821
New
56
Increased
555
Reduced
957
Closed
250

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$101M
2
AMZN icon
Amazon
AMZN
+$99.5M
3
MSFT icon
Microsoft
MSFT
+$95.8M
4
LIN icon
Linde
LIN
+$84.2M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 19.27%
2 Healthcare 13.08%
3 Financials 12.21%
4 Consumer Discretionary 10.94%
5 Consumer Staples 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
76
Bank of America
BAC
$430B
$64.5M 0.45%
2,618,264
+15,464
+0.6% +$420K
ADM icon
77
Archer Daniels Midland
ADM
$41.4B
$62.8M 0.44%
1,533,039
+4,491
+0.3% +$209K
TGT icon
78
Target
TGT
$63.4B
$61.7M 0.43%
932,899
-19,546
-2% -$1.5M
BKNG icon
79
Booking.com
BKNG
$141B
$61M 0.43%
885,600
+164,500
+23% +$12.1M
HD icon
80
Home Depot
HD
$338B
$60.7M 0.42%
353,204
+104,822
+42% +$18.8M
SBUX icon
81
Starbucks
SBUX
$120B
$58.9M 0.41%
913,838
+167,718
+22% +$10.5M
QCOM icon
82
Qualcomm
QCOM
$181B
$56.2M 0.39%
986,769
+42,439
+4% +$2.58M
WFC icon
83
Wells Fargo
WFC
$265B
$52.3M 0.37%
1,134,049
+3,082
+0.3% +$158K
PFE icon
84
Pfizer
PFE
$143B
$49.8M 0.35%
1,202,205
+132,491
+12% +$5.5M
CELG
85
DELISTED
Celgene Corp
CELG
$49.4M 0.35%
770,690
+73,347
+11% +$5.41M
ILMN icon
86
Illumina
ILMN
$28.2B
$49.3M 0.35%
169,067
+22,147
+15% +$6.86M
GS icon
87
Goldman Sachs
GS
$314B
$47.2M 0.33%
282,277
+90,328
+47% +$18.2M
MRK icon
88
Merck
MRK
$315B
$46.4M 0.33%
636,935
+105,608
+20% +$7.46M
CHTR icon
89
Charter Communications
CHTR
$16.2B
$46.3M 0.32%
162,331
+39,953
+33% +$12.5M
VRTX icon
90
Vertex Pharmaceuticals
VRTX
$123B
$44.6M 0.31%
269,377
+26,403
+11% +$4.57M
MA icon
91
Mastercard
MA
$480B
$43.9M 0.31%
232,787
+7,165
+3% +$1.42M
MDLZ icon
92
Mondelez International
MDLZ
$78.3B
$42.8M 0.3%
1,068,635
+262,020
+32% +$11.2M
DIS icon
93
Walt Disney
DIS
$170B
$42.3M 0.3%
385,750
+101,910
+36% +$11.6M
VZ icon
94
Verizon
VZ
$182B
$42.3M 0.3%
751,787
+142,044
+23% +$8.06M
ISRG icon
95
Intuitive Surgical
ISRG
$122B
$41.7M 0.29%
260,973
+51,390
+25% +$8.71M
INTU icon
96
Intuit
INTU
$79.6B
$41.6M 0.29%
211,122
+43,186
+26% +$8.99M
CSX icon
97
CSX Corp
CSX
$94.3B
$39.6M 0.28%
1,911,099
+437,580
+30% +$10.1M
REGN icon
98
Regeneron Pharmaceuticals
REGN
$70.9B
$39.3M 0.28%
105,253
+13,338
+15% +$4.88M
TFCFA
99
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$39M 0.27%
810,596
+195,072
+32% +$9.25M
IBM icon
100
IBM
IBM
$200B
$38M 0.27%
349,461
+76,345
+28% +$9.16M

Similar funds

ProShare Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, ProShare Advisors held 1,821 positions worth $14.3B, down 3% from $14.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

ProShare Advisors deployed $1.68B of net new capital in Q4 2018, opening 56 new positions and adding to 555 existing holdings. Its largest new stake was Linde: 532,831 shares worth $83.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was McCormick & Company Non-Voting, an estimated $14.7M trimmed.

  • ProShare Advisors's largest Q4 2018 buy was Linde: 532,831 shares worth $83.1M.
  • ProShare Advisors added most to Apple in Q4 2018, an estimated $101M increase.
  • ProShare Advisors's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $14.7M.
  • ProShare Advisors fully exited Praxair Inc in Q4 2018, selling an estimated $77.4M.
  • ProShare Advisors's ten largest holdings make up 22% of its $14.3B portfolio in Q4 2018.
  • ProShare Advisors opened 56 new positions and closed 250 in Q4 2018.
  • ProShare Advisors's portfolio value fell 3% quarter-over-quarter to $14.3B.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.